We've got news for you.

Register on Sunday Times at no cost to receive newsletters, read exclusive articles & more.
Register now

Kicking HER where it hurts: ‘practice-changing’ breast cancer ...


Kicking HER where it hurts: ‘practice-changing’ breast cancer drug unveiled

Early success of Enhertu bodes well for entire class of medicines that may one day replace conventional chemotherapy

Lisa Jarvis

New data on a breast cancer treatment from AstraZeneca and the Japanese drug maker Daiichi Sankyo brought a standing ovation from cancer doctors attending their annual meeting in Chicago on Sunday. And with good reason.

The drug, Enhertu, enabled women with advanced breast cancer to live six months longer than others treated with conventional chemotherapy. Oncologists call the results “practice-changing” for metastatic breast cancer.

And the good news extends well beyond breast cancer. The evidence suggests the drug could one day be used to treat many other types of tumours, opening broad opportunities for Enhertu and other drugs like it...

This article is reserved for Sunday Times Daily subscribers.
A subscription gives you full digital access to all Sunday Times Daily content.

Sunday Times Daily

Already subscribed? Simply sign in below.

Questions or problems?
Email helpdesk@timeslive.co.za or call 0860 52 52 00.

Previous Article